TruBrain

About the offering

TruBrain, operating as TriplePulse, Inc., is a cognitive health brand headquartered in Sacramento, CA, with $25 million in lifetime sales and a presence in over 80 countries. The company is best known for its nootropic food and beverage products — including capsules, drinks, gummies, ketone supplements, and hydration products — designed to enhance cognitive performance and mental clarity. TruBrain was founded on the basis of neuroscience research, studying brainwave patterns of high performers such as surgeons, artists, and CEOs, to develop products that support optimal brain function. The company is now expanding into wearable technology, launching a device specifically targeting anxiety. The wearable is designed to offer a non-pharmaceutical approach to managing anxiety using Cranial Electrotherapy Stimulation (CES) technology — the same category of technology found in FDA-cleared devices, though TruBrain's specific wearable has not itself received FDA clearance and is not yet commercially available. The device was developed in collaboration with Tridi Teknoloji and a European industrial design team, and was designed by PhD neuroscientists. TruBrain has received 250+ pre-launch reservations for the device. The company is pursuing a Class II medical device regulatory pathway for anxiety (rather than Class III for depression), which it believes reduces time, cost, and regulatory risk. The anxiety treatment market is cited at $11 billion, with WHO data indicating a 25% increase in global anxiety prevalence since 2020. TruBrain's leadership team includes CEO Chris Thompson, a former Unilever executive who managed billion-dollar CPG brands, and Dr. Andrew Hill, a neuroscientist who leads the company's neurotechnology and EEG research efforts. The company is raising funds via Regulation Crowdfunding (Reg CF) on StartEngine at $0.43 per share of Common Stock, with a pre-money valuation of $30.5 million. The offering goal ranges from $20,000 to $5 million. Investors receive proxy voting rights assigned to the CEO. Investment perks include product bundles, lifetime discounts, bonus shares, beta test group access, and annual CEO calls, tiered from $1,000 to $25,000+ investment levels. The company has been featured in Forbes, CNBC, and Bloomberg.

FAQ